Company

News

World’s most in depth study to detect Alzheimer’s hopes to identify early signs of the disease

Posted on 22 August 2016

A new multimillion pound study, which will see the most thorough and rigorous series of tests to detect Alzheimer’s disease ever performed on volunteers, is announced today.

Read on

Early Phase Development of Centrally-Acting Drugs

Posted on 9 August 2016

Altasciences Clinical Research and Cambridge Cognition join forces for a complimentary scientific symposium for members of the pharmaceutical and biotech communities to discuss and share ideas on early phase development of centrally acting drugs.

Read on

Differential Effects of APOE and CSF Amyloid on Memory Impairment in Individuals with Amnestic MCI

Posted on 26 July 2016

New data presented at AAIC 2016 on Tuesday 26th July on differential effects of APOE and CSF Amyloid on memory impairment in individuals with Amnestic MCI using CANTAB.

Read on

The Predictive Utility of Cognitive Measures at Screening for Prodromal Alzheimer’s disease

Posted on 26 July 2016

New data presented at AAIC 2016 on Tuesday 26th July on the predictive utility of cognitive measures at screening for determination of CSF Aβ(1-42) status in subjects with prodromal Alzheimer's disease.

Read on